Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Slakman BL"'
Autor:
Li ASM; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Kimani S; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2C1, Canada., Wilson B; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., Noureldin M; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., González-Álvarez H; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Mamai A; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., Hoffer L; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., Guilinger JP; X-Chem Inc., Waltham, Massachusetts 02453, United States., Zhang Y; X-Chem Inc., Waltham, Massachusetts 02453, United States., von Rechenberg M; Relay Therapeutics, Cambridge, Massachusetts 02139, United States., Disch JS; Relay Therapeutics, Cambridge, Massachusetts 02139, United States., Mulhern CJ; Relay Therapeutics, Cambridge, Massachusetts 02139, United States., Slakman BL; Relay Therapeutics, Cambridge, Massachusetts 02139, United States., Cuozzo JW; Relay Therapeutics, Cambridge, Massachusetts 02139, United States., Dong A; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada., Poda G; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada., Mohammed M; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., Saraon P; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., Mittal M; Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Ahmedabad, Gujarat 382213, India., Modh P; Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Ahmedabad, Gujarat 382213, India., Rathod V; Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Ahmedabad, Gujarat 382213, India., Patel B; Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Ahmedabad, Gujarat 382213, India., Ackloo S; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada., Santhakumar V; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada., Szewczyk MM; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada., Barsyte-Lovejoy D; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Arrowsmith CH; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2C1, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada., Marcellus R; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada., Guié MA; X-Chem Inc., Waltham, Massachusetts 02453, United States., Keefe AD; X-Chem Inc., Waltham, Massachusetts 02453, United States., Brown PJ; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada., Halabelian L; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Al-Awar R; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada., Vedadi M; Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Apr 13; Vol. 66 (7), pp. 5041-5060. Date of Electronic Publication: 2023 Mar 22.
Autor:
Bhoorasingh PL; Department of Chemical Engineering, Northeastern University , Boston, Massachusetts 02115, United States., Slakman BL; Department of Chemical Engineering, Northeastern University , Boston, Massachusetts 02115, United States., Seyedzadeh Khanshan F; Department of Chemical Engineering, Northeastern University , Boston, Massachusetts 02115, United States., Cain JY; Department of Chemical Engineering, Northeastern University , Boston, Massachusetts 02115, United States., West RH; Department of Chemical Engineering, Northeastern University , Boston, Massachusetts 02115, United States.
Publikováno v:
The journal of physical chemistry. A [J Phys Chem A] 2017 Sep 21; Vol. 121 (37), pp. 6896-6904. Date of Electronic Publication: 2017 Sep 12.